Dynavax Technologies reported $221.03M in Loan Capital for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Loan Capital Change
Amgen AMGN:US USD 37.35B 193M
AstraZeneca AZN:LN USD 23.68B 3.47B
Astrazeneca AZN:US USD 23.68B 3.47B
Biogen BIIB:US USD 6.28B 1.8M
Biomarin Pharmaceutical BMRN:US USD 1.08B 986K
Bristol Myers Squibb BMY:US USD 36.97B 141M
Gilead Sciences GILD:US USD 22.95B 2.24B
Glaxosmithkline GSK:US GBP 19.32B 3.55B
Merk MRK:US USD 28.48B 202M
Novartis NOVN:VX USD 21.24B 2.55B
Regeneron Pharmaceuticals REGN:US USD 2.7B 400K
Roche Holding ROG:VX 22.37B 6.29B
Sarepta Therapeutics SRPT:US USD 1.54B 441.9M
Tg Therapeutics TGTX:US USD 70.04M 1.09M
Vertex Pharmaceuticals VRTX:US USD 442.3M 40M